Drug Approval | March 10, 2023
Zydus receives final approval from the USFDA for Erythromycin Tablets
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
Ashland’s pharmaceutical business is well known for acetylenics, cellulosics, and film coatings
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Digital success is contingent on the way a company organizes itself around technology
Vigabatrin for Oral Solution USP, 500 mg had annual sales of US $233.7 mn in US
Vigabatrin for Oral Solution USP, 500 mg had annual sales of USD 233.7 mn in the United States
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
he product will be launched shortly in the US market.
Subscribe To Our Newsletter & Stay Updated
